Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function - A report from the Acute Decompensated Heart Failure National Registry (ADHERE) database

被引:716
作者
Yancy, CW
Lopatin, M
Stevenson, LW
De Marco, T
Fonarow, GC
机构
[1] Univ Texas, SW Med Ctr, Dept Med, Div Cardiol, Dallas, TX 75390 USA
[2] Scios Inc, Dept Biostat, Fremont, CA USA
[3] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA
[4] Univ Calif San Francisco, Dept Med, Div Cardiol, San Francisco, CA 94143 USA
[5] Univ Calif Los Angeles, Med Ctr, Ahmanson UCLA Cardiomyopathy Ctr, Los Angeles, CA 90024 USA
关键词
D O I
10.1016/j.jacc.2005.09.022
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The aims of this analysis were to describe the clinical characteristic,,, management, and outcomes of patients hospitalized for acute decompensated heart failure (HF) with preserved systolic function (PSF). BACKGROUND Clinically meaningful characteristics of these patients have not been fully, studied in a large database. METHODS Data from >100,000 hospitalizations from the Acute Decompensated Heart Failure National Registry (ADHERE) database were analyzed. RESULTS Heart failure with PSF was present in 50.4% of patients with in-hospital assessment of left ventricular function. When compared with patients with systolic dysfunction, patients with PSF were more likely to be older, women, and hypertensive and less likely to have had a prior myocardial infarction or be receiving an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker. In-hospital mortality was lower in patients with PSF compared with patients with systolic dysfunction (2.8% vs. 3.9%; adjusted odds ratio [OR]: 0,86; p = 0.005), but duration of intensive care unit stay, and total hospital length of stay were similar. Serum creatinine >2 mg/dl was associated with increased in-hospital mortality in both systolic function groups (PSF: 4.8%; systolic dysfunction: 8.41%; p < 0.0001), and the most powerful predictors of in-hospital mortality in both groups were blood urea nitrogen >37 mg/dl (OR: 2.53; 95% confidence interval [CI]: 2.22 to 2.87) and systolic blood pressure <= 125 mm Hg (OR: 2.58; 95% CI: 2.33 to 2.86). CONCLUSIONS Heart failure with PSF is common and is characterized by a unique patient profile. Event rates are worrisome and reflect a need for more effective management strategies.
引用
收藏
页码:76 / 84
页数:9
相关论文
共 29 条
  • [1] Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000, cases in the Acute Decompensated Heart Failure National Registry (ADHERE)
    Adams, KF
    Fonarow, GC
    Emerman, CL
    LeJemtel, TH
    Costanzo, MR
    Abraham, WT
    Berkowitz, RL
    Galvao, M
    Horton, DP
    [J]. AMERICAN HEART JOURNAL, 2005, 149 (02) : 209 - 216
  • [2] Adams KF, 2003, CIRCULATION, V108, P695
  • [3] Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction
    Al-Ahmad, A
    Rand, WM
    Manjunath, G
    Konstam, MA
    Salem, DN
    Levey, AS
    Sarnak, MJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (04) : 955 - 962
  • [4] American Heart Association/American Stroke Association, 2014, HEART DIS STROK STAT
  • [5] [Anonymous], 2002, JAMA, V287, P1531
  • [6] SmcHD1, containing a structural-maintenance-of-chromosomes hinge domain, has a critical role in X inactivation
    Blewitt, Marnie E.
    Gendrel, Anne-Valerie
    Pang, Zhenyi
    Sparrow, Duncan B.
    Whitelaw, Nadia
    Craig, Jeffrey M.
    Apedaile, Anwyn
    Hilton, Douglas J.
    Dunwoodie, Sally L.
    Brockdorff, Neil
    Kay, Graham F.
    Whitelaw, Emma
    [J]. NATURE GENETICS, 2008, 40 (05) : 663 - 669
  • [7] Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
    Chobanian, AV
    Bakris, GL
    Black, HR
    Cushman, WC
    Green, LA
    Izzo, JL
    Jones, DW
    Materson, BJ
    Oparil, S
    Wright, JT
    Roccella, EJ
    [J]. HYPERTENSION, 2003, 42 (06) : 1206 - 1252
  • [8] Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure.
    Colucci, WS
    Elkayam, U
    Horton, DP
    Abraham, WT
    Bourge, RC
    Johnson, AD
    Wagoner, LE
    Givertz, MM
    Liang, CS
    Neibaur, M
    Haught, WH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (04) : 246 - 253
  • [9] Short-term intravenous milrinone for acute exacerbation of chronic heart failure - A randomized controlled trial
    Cuffe, MS
    Califf, RM
    Adams, KF
    Benza, R
    Bourge, R
    Colucci, WS
    Massie, BM
    O'Connor, CM
    Pina, I
    Quigg, R
    Silver, MA
    Georghiade, M
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (12): : 1541 - 1547
  • [10] Eplerenone prevents salt-induced vascular remodeling and cardiac fibrosis in stroke-prone spontaneously hypertensive rats
    Endemann, DH
    Touyz, RM
    Iglarz, M
    Savoia, C
    Schiffrin, EL
    [J]. HYPERTENSION, 2004, 43 (06) : 1252 - 1257